These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6686766)

  • 1. Synthesis and biological activities of the tri-L-alanine derivative of isonicotinic acid hydrazide.
    Brückner H; Jung G; Werner RG; Appel KR
    Arzneimittelforschung; 1983; 33(12):1630-3. PubMed ID: 6686766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
    Kumar A; Patel G; Menon SK
    Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI.
    Vigorita MG; Ottanà R; Maccari R; Monforte F; Bisignano G; Pizzimenti FC
    Boll Chim Farm; 1998; 137(7):267-76. PubMed ID: 9795482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide.
    Mossa JS; El-Feraly FS; Muhammad I
    Phytother Res; 2004 Nov; 18(11):934-7. PubMed ID: 15597311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
    Seydel JK; Schaper KJ; Wempe E; Cordes HP
    J Med Chem; 1976 Apr; 19(4):483-92. PubMed ID: 817022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the therapeutic action of ketonic isonicotinic acid hydrazides in experimental tuberculosis in guinea pigs (isonicotinic acid hydrazide oxalacetate, isonicotinic acid hydrazide mercaptopyruvate, isonicotinic acid hydrazide brompyruvate, isonicotinoyl alpha-ketoglutaric acid, levulinic isonicotinic acid hydrazide)].
    OERIU S; RADULESCU D; VASILESCU C; ZIRRA AM; CHIRESCU N; WINTER D
    Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1956; 8(3):859-66. PubMed ID: 13413322
    [No Abstract]   [Full Text] [Related]  

  • 9. Cuprous complexes formed with isonicotinic hydrazide.
    Krivis AF; Rabb JM
    Science; 1969 May; 164(3883):1064-5. PubMed ID: 4976919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the metabolic fate and mechanism of antituberculous activity of derivatives of isonicotinic acid hydrazide. II. The antituberculous activity of derivatives of isonicotinic acid hydrazide].
    SHIMOMURA Y
    Kekkaku; 1957 Oct; 32(10):535-8. PubMed ID: 13492361
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N(2)-acyl isonicotinic acid hydrazide derivatives.
    Judge V; Narasimhan B; Ahuja M; Sriram D; Yogeeswari P; De Clercq E; Pannecouque C; Balzarini J
    Med Chem; 2013 Feb; 9(1):53-76. PubMed ID: 22762163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents.
    Grover G; Kini SG
    Eur J Med Chem; 2006 Feb; 41(2):256-62. PubMed ID: 16260068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of alpha-thiophenylglycine peptides. Novel peptide substrates useful in the study of microbial peptide transport.
    Kingsbury WD; Boehm JC
    Int J Pept Protein Res; 1986 Jun; 27(6):659-65. PubMed ID: 3531054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of d-cycloserine & isonicotinic acid hydrazide on the catalase activity of Mycobacteria].
    ANDREJEW A; GERNEZ-RIEUX C; TACQUET A
    Biochim Biophys Acta; 1958 Oct; 30(1):102-11. PubMed ID: 13584402
    [No Abstract]   [Full Text] [Related]  

  • 15. Nevirapine derivatives with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
    Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
    Biomed Pharmacother; 2005 Sep; 59(8):456-9. PubMed ID: 16140495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition metal complexes of isonicotinic acid (2-hydroxybenzylidene)hydrazide.
    Abou-Melha KS
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):162-70. PubMed ID: 17728178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in morphology and mode of development of tubercle bacilli and other mycobacteria caused by antituberculous agents. II. The changes in the initial minute colonies of mycobacteria caused by isonicotinic acid hydrazide].
    ITO Y
    Kekkaku; 1958 Jun; 33(6):408-11; English abstract 445. PubMed ID: 13564623
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and antimycobacterial activity of nitroxanthones. 2nd communication: antimycobacterial activity.
    Ibrom WG; Schaper KJ; Frahm AW
    Arzneimittelforschung; 1997 Jun; 47(6):767-73. PubMed ID: 9239457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.